These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7576950

  • 1. Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.
    Bjellerup P, Theodorsson E, Kogner P.
    Eur J Cancer; 1995; 31A(4):481-5. PubMed ID: 7576950
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin in neuroblastoma and ganglioneuroma.
    Kogner P, Borgström P, Bjellerup P, Schilling FH, Refai E, Jonsson C, Dominici C, Wassberg E, Bihl H, Jacobsson H, Theodorsson E, Hassan M.
    Eur J Cancer; 1997 Oct; 33(12):2084-9. PubMed ID: 9516858
    [Abstract] [Full Text] [Related]

  • 3. Pancreastatin immunoreactivity in favourable childhood neuroblastoma and ganglioneuroma.
    Kogner P, Bjellerup P, Svensson T, Theodorsson E.
    Eur J Cancer; 1995 Oct; 31A(4):557-60. PubMed ID: 7576967
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
    Scheibel E, Rechnitzer C, Fahrenkrug J, Hertz H.
    Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
    [Abstract] [Full Text] [Related]

  • 5. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
    Kogner P, Björk O, Theodorsson E.
    Med Pediatr Oncol; 1993 Sep; 21(5):317-22. PubMed ID: 8492745
    [Abstract] [Full Text] [Related]

  • 6. Vasocative intestinal polypeptide (VIP)-producing ganglioneuroma in a child with chronic diarrhea.
    Hansen LP, Lund HT, Fahrenkrug J, Søgaard H.
    Acta Paediatr Scand; 1980 May; 69(3):419-24. PubMed ID: 7376870
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide secreting tumours in children: a case report with literature review.
    Quak SH, Prabhakaran K, Kwok R, O'Reilly AP.
    Aust Paediatr J; 1988 Feb; 24(1):55-8. PubMed ID: 2833214
    [Abstract] [Full Text] [Related]

  • 8. PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP.
    Fahrenkrug J, Buhl T, Hannibal J.
    Regul Pept; 1995 Aug 22; 58(3):89-98. PubMed ID: 8577931
    [Abstract] [Full Text] [Related]

  • 9. Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.
    Tiedemann K, Pritchard J, Long R, Bloom SR.
    Eur J Pediatr; 1981 Oct 22; 137(2):217-9. PubMed ID: 6118274
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin and vasoactive intestinal polypeptide-like immunoreactive cells and terminals in the retrohippocampal region of the rat brain.
    Köhler C, Chan-Palay V.
    Anat Embryol (Berl); 1983 Oct 22; 167(2):151-72. PubMed ID: 6137169
    [Abstract] [Full Text] [Related]

  • 11. Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus.
    Gomariz RP, Lorenzo MJ, Cacicedo L, Vicente A, Zapata AG.
    Brain Behav Immun; 1990 Jun 22; 4(2):151-61. PubMed ID: 1975506
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y- and somatostatin-like immunoreactivities in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
    Takahashi K, Mouri T, Itoi K, Sone M, Hayashi Y, Murakami O, Ohneda M, Ohi R, Yoshinaga K.
    Endocrinol Jpn; 1989 Oct 22; 36(5):627-33. PubMed ID: 2620662
    [Abstract] [Full Text] [Related]

  • 13. Intractable diarrhea in children with VIP-secreting ganglioneuroblastomas.
    El Shafie M, Samuel D, Klippel CH, Robinson MG, Cullen BJ.
    J Pediatr Surg; 1983 Feb 22; 18(1):34-6. PubMed ID: 6834224
    [Abstract] [Full Text] [Related]

  • 14. Regulatory peptides in neuronal neoplasms of the central nervous system.
    Giangaspero F, Burger PC, Budwit DA, Usellini L, Mancini AM.
    Clin Neuropathol; 1985 Feb 22; 4(3):111-5. PubMed ID: 2861927
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal polypeptide-like immunoreactivity in a human neuroblastoma cell line and the coexistence of other neuropeptide immunoreactivity in the cell line.
    Yanaihara N, Kobayashi S, Sato H, Yanaihara C, Sakagami M, Sakura N, Hashimoto T, Ishikawa S, Iwanaga T, Fujita T.
    Endocrinol Jpn; 1980 Dec 22; 27 Suppl 1():37-42. PubMed ID: 6164547
    [Abstract] [Full Text] [Related]

  • 16. Tumor with watery diarrhoea, hypokalaemia in a 3-year-old girl.
    Zhang WQ, Liu JF, Zhao J, Zhao SY, Xue Y.
    Eur J Pediatr; 2009 Jul 22; 168(7):859-62. PubMed ID: 19101728
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-alpha and epidermal growth factor inhibit gastric acid secretion and stimulate release of somatostatin and neurotensin in the conscious rat.
    Grupcev G, Wallin C, Emås S, Theodorsson E, Hellström PM.
    Regul Pept; 1994 Jul 14; 52(2):111-8. PubMed ID: 7972934
    [Abstract] [Full Text] [Related]

  • 18. Co-existence and co-secretion of the structurally related peptides VIP and PHI.
    Fahrenkrug J.
    Scand J Clin Lab Invest Suppl; 1987 Jul 14; 186():43-50. PubMed ID: 3474771
    [Abstract] [Full Text] [Related]

  • 19. Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors.
    Qualman SJ, O'Dorisio MS, Fleshman DJ, Shimada H, O'Dorisio TM.
    Cancer; 1992 Oct 01; 70(7):2005-12. PubMed ID: 1381992
    [Abstract] [Full Text] [Related]

  • 20. The response of a non-functional VIP- and somatostatin-containing tumour to tolbutamide in vitro.
    Woltering EA, O'Dorisio TM, Mekhjian HS, Ellison EC, Dyben T, Howe BA, Tuttle SE, Minton JP.
    Scand J Gastroenterol Suppl; 1986 Oct 01; 119():129-35. PubMed ID: 2876496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.